Skip to main content

Table 1 Demographic and laboratory characteristics at baseline

From: The diagonal branches and outcomes in patients with anterior ST- elevation myocardial infarction

VariablesTotal (n = 392)Flow of the main diagonal branches of LADp Value
loss (TIMI 0–1) (n = 69)no loss (TIMI 2–3) (n = 323)
Age, years, mean ± SD63.9 ± 11.664.7 ± 12.263.8 ± 11.40.60
Female, n(%)68(17.3)14(20.3)54(16.7)0.48
Diabetes, n(%)103(26.3)24(34.8)79(24.5)0.08
Hypertension, n(%)232(59.2)38(55.1)194(60.1)0.44
Smoking history, n(%)164(41.8)22(31.9)142(44)0.07
Stroke, n(%)26(6.6)6(8.7)20(6.2)0.45
Family history of CAD, n(%)8(2)08(2.5)0.36
Previous CAD, n(%)26(6.6)6(8.7)20(6.2)0.43
Valve calcification, n(%)86(21.9)13(18.8)73(22.6)0.49
Time from symptom onset to hospital, hours6(4–10)6(4–9)6(4–10)0.35
 0-3 h, n(%)88(22.4)15(21.7)73(22.6)0.42
 3-6 h, n(%)117(29.8)25(36.2)92(28.5)
 6-12 h, n(%)187(47.7)29(42)158(48.9)
LVEF, %, mean ± SD47.4 ± 13.241 ± 18.348.8 ± 11.40.003
Killip class> 2, n(%)16(4.1)8(11.6)8(2.5)0.001
SBP, mmHg, mean ± SD123 ± 31.6109.0 ± 34.3126.1 ± 30.20.36
TC, mmol/L, mean ± SD4.4 ± 1.14.6 ± 1.34.3 ± 0.90.09
LDL-C, mmol/L2.6(2–3.2)2.5(1.7–3.3)2.5(1.9–3.2)0.89
CRP, mg/L6.7(3–12.1)4.2(1–10.2)6.6(3–10.8)0.23
Scr, μmol/L68.5(57–82.8)73.5(63.8–86)71(60–87)0.71
cTNT, ng/ml0.2(0.05–0.75)0.11(0.04–0.64)0.26(0.06–0.78)0.08
CKMB, U/L27(14–63)21(14.8–104)30.5(16–69.3)0.46
NT-proBNP, pg/ml227.6(59.4–922.9)126.1(49.4–429.5)236.4(57.7–1142.3)0.16
Medications during hospital
 Aspirin, n(%)363(92.6)64(92.8)299(92.6)0.96
 Clopidogrel, n(%)247(63)41(59.4)206(63.8)0.50
 Ticagrelor, n(%)145(37)28(40.6)117(36.2)0.49
 GPIIb/IIIa receptor antagonists, n(%)248(63.3)44(63.8)204(63.2)0.91
 AECI/ARB, n(%)381(97.2)67(97.1)314(97.2)0.98
 β-receptor blocker, n(%)387(98.7)68(98.6)319(98.8)0.98
 Statin, n(%)392(100)69(100)323(100)0.99
Hospital stay, days, mean ± SD8.1 ± 3.88.9 ± 47.9 ± 3.80.07
  1. SD Standard deviation, LAD, Left anterior descending artery, CAD Coronary artery diseasem, SBP Systolic blood pressure, TC Total cholesterol, LDL Low density lipoprotein, CRP C–reactive protein, Scr Serum creatinine, cTNT Cardiac troponin T, CK-MB Creatine Kinase MB; LVEF Left ventricular ejection fraction, NT-proBNP N-terminal pro B-type natriuretic peptide, ACEI/ARB Angiotensin converting enzyme inhibition/angiotensin II receptor blockers